CompletedNCT00835523
Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist
Studying Ovarian hyperstimulation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Schleswig-Holstein
- Principal Investigator
- Georg Griesinger, PD Dr. med.Department of Obestrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Luebeck
- Enrollment
- 51 target
- Eligibility
- 18-39 years · All sexes
- Timeline
- 2008 – 2010
Study locations (10)
- IVF-Augsburg, Augsburg, Germany
- Deutsche Klinik Bad Münder, Bad Münder am Deister, Germany
- Department of Obestrics and Gynecology, University Bonn, Bonn, Germany
- Department of Obestrics and Gynecology, University Cologne, Cologne, Germany
- Interdisziplinäres Kinderwunschzentrum, Düsseldorf, Germany
- University Centre for Reproductive Medicine Franken, Erlangen, Germany
- Department of Obestrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany
- Department of Obestrics and Gynecology, University Magdeburg, Magdeburg, Germany
- Kinderwunschpraxis, Tübingen, Germany
- Department of Obestrics and Gynecology, University Wuerzburg, Würzburg, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00835523 on ClinicalTrials.govOther trials for Ovarian hyperstimulation syndrome
Additional recruiting or active studies for the same condition.